Skip to content
zameds

Methylphenidate (Acerta)

Methylphenidate

Teva Pharmaceuticals (Pty) Ltd

S6Read from the PI-PIL document and verified

Registration

Applicant
Teva Pharmaceuticals (Pty) Ltd
Certificate holder
Teva Pharmaceuticals (Pty) Ltd
Registrations
4
Schedule source
SAHPRA documentation

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Acerta 18

EACH TABLET CONTAINS: METHYLPHENIDATE HYDROCHLORIDE 18,0 mg

18Prolonged release tablets.51028551/1.2/0285Approved 28 October 2024RegisteredS6PIPIL
Acerta 27

EACH TABLET CONTAINS: METHYLPHENIDATE HYDROCHLORIDE 27,0 mg

27Prolonged release tablets.51028651/1.2/0286Approved 28 October 2024RegisteredS6PIPIL
Acerta 36

EACH TABLET CONTAINS: METHYLPHENIDATE HYDROCHLORIDE 36,0 mg

36Prolonged release tablets.51028751/1.2/0287Approved 28 October 2024RegisteredS6PIPIL
Acerta 54

EACH TABLET CONTAINS: METHYLPHENIDATE HYDROCHLORIDE 54,0 mg

54Prolonged release tablets.51028851/1.2/0288Approved 28 October 2024RegisteredS6PIPIL

Regulatory status

Where S6 sits on the scale

Prescription-only, no repeats without a new prescription.

Schedule 6 covers the most tightly controlled ordinary prescription medicines. Every dispensing needs its own new prescription; nothing can be repeated on the same script. When prescribed, the quantity must be written out in both figures and words. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S6, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.

Consolidated Schedules listings for Methylphenidate hydrochloride

  • S6: Methylphenidate

    • and its derivatives, unless listed in another Schedule.

    Consolidated Schedules 06 July 2026, line 10310

Pharmacological class: Psychoanaleptics (antidepressants). (class 1.2)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C14H19NO2233.31 g/mol

Methyl 2-phenyl-2-piperidin-2-ylacetate

Drag to rotate. Structure from PubChem CID 4158.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

This medication's schedule (S6) has been verified from official SAHPRA documents with 90% confidence.

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles